Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Cancer Supportive Care Market Portraiture
2.2 Global Cancer Supportive Care Market (US$ Mn), by Therapeutic Area, 2015
2.3 Global Cancer Supportive Care Market (US$ Mn), by Cancer Type, 2015
2.4 Global Cancer Supportive Care Market (US$ Mn), by Sales Channel, 2015
2.5 Global Cancer Supportive Care Market Share (Value %), by Geography, 2015
Chapter 3 Global Cancer Supportive Care Market Overview
3.1 Overview
3.2 Major Drug Classes Assessment
3.2.1 Anti-infectives
3.2.2 Anti-emetics
3.2.3 Biophosphonates
3.2.4 Granulocyte Stimulating Agents
3.2.5 Erythropoietin Stimulating Agents
3.2.6 Opioid Analgesics
3.2.7 NSAIDS
3.2.8 Monoclonal Antibodies
3.3 Market Dynamics
3.3.1 Drivers
3.3.2 Challenges
3.3.3 Opportunities
3.4 Attractive Investment Proposition
3.5 Market Competition Assessment: Cancer Supportive Care Market, by Key Players
Chapter 4 Global Cancer Supportive Care Market (US$ Mn), By Therapeutic Area, 2013-2024
4.1 Introduction
4.2 Oral Mucositis and Dry Mouth
4.3 Chemotherapy Induced Nausea and Vomiting
4.4 Cancer Pain
4.5 Chemotherapy Induced Anemia
4.6 Chemotherapy Induced Neutropenia
4.7 Bone Metastases
Chapter 5 Global Cancer Supportive Care Market (US$ Mn), By Cancer Type, 2013-2024
5.1 Introduction
5.2 Lung Cancer
5.3 Liver Cancer
5.4 Breast Cancer
5.5 Leukemia
5.6 Prostate Cancer
5.7 Ovarian Cancer
5.8 Bladder Cancer
5.9 Others
Chapter 6 Global Cancer Supportive Care Market (US$ Mn), By Sales Channel, 2013-2024
6.1 Introduction
6.2 Hospital Pharmacies
6.3 Retail Pharmacies
6.4 Compounding Pharmacies
Chapter 7 Global Cancer Supportive Care Market (US$ Mn), By Geography, 2013-2024
7.1 Preface
7.2 North America (U.S., Canada)
7.3 Europe (U.K., Germany, Rest of Europe)
7.4 Asia Pacific (Japan, China, Australia, Rest of Asia Pacific)
7.5 Latin America (Brazil, Mexico, Rest of LATAM)
7.6 Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)
Chapter 8 Company Profiles
8.1 Amgen Inc.
8.2 Novartis AG
8.3 Johnson & Johnson
8.4 Pfizer
8.5 Teva Pharmaceutical Industries Ltd.
8.6 F. Hoffmann-La Roche Ltd.
8.7 Baxter International Inc.
8.8 Fagron Group BV
8.9 Helsinn Group
8.10 Acacia Pharma Ltd.
List of Figures
FIG. 1 Cancer Supportive Care Market: Research Methodology
FIG. 2 Global Cancer Supportive Care Market (US$ Mn), by Therapeutic Area, 2015
FIG. 3 Global Cancer Supportive Care Market (US$ Mn), by Cancer Type, 2015
FIG. 4 Global Cancer Supportive Care Market (US$ Mn), by Sales Cannel, 2015
FIG. 5 Global Cancer Supportive Care Market (Value %), by Geography, 2015
FIG. 6 Attractive Investment Proposition, by Geography, 2015
FIG. 7 Market Positioning of Key Cancer Supportive Care Companies, 2015
FIG. 8 Oral Mucositis and Dry Mouth Therapeutics Market (US$ Mn), 2013–2024
FIG. 9 Chemotherapy Induced Nausea and Vomiting Therapeutics Market (US$ Mn), 2013–2024
FIG. 10 Cancer Pain Therapeutics Market (US$ Mn), 2013–2024
FIG. 11 Chemotherapy Induced Anemia Therapeutics Market (US$ Mn), 2013–2024
FIG. 12 Chemotherapy Induced Neutropenia Therapeutics Market (US$ Mn), 2013–2024
FIG. 13 Bone Metastases Therapeutics Market (US$ Mn), 2013–2024
FIG. 14 Cancer Supportive Care Market in Lung Cancer (US$ Mn), 2013–2024
FIG. 15 Cancer Supportive Care Market in Liver Cancer (US$ Mn), 2013–2024
FIG. 16 Cancer Supportive Care Market in Breast Cancer (US$ Mn), 2013–2024
FIG. 17 Cancer Supportive Care Market in Leukemia (US$ Mn), 2013–2024
FIG. 18 Cancer Supportive Care Market in Prostate Cancer (US$ Mn), 2013–2024
FIG. 19 Cancer Supportive Care Market in Ovarian Cancer (US$ Mn), 2013–2024
FIG. 20 Cancer Supportive Care Market in Bladder Cancer (US$ Mn), 2013–2024
FIG. 21 Cancer Supportive Care Market in Other Cancers (US$ Mn), 2013–2024
FIG. 22 Cancer Supportive Care Market in Hospital Pharmacies (US$ Mn), 2013–2024
FIG. 23 Cancer Supportive Care Market in Retail Pharmacies (US$ Mn), 2013–2024
FIG. 24 Cancer Supportive Care Market in Compounding Pharmacies (US$ Mn), 2013–2024
List of Tables
TABLE 1 Global Cancer Supportive Care Market (US$ Mn), By Therapeutic Area, 2013-2024
TABLE 2 Global Cancer Supportive Care Market (US$ Mn), By Cancer Type, 2013-2024
TABLE 3 Global Cancer Supportive Care Market (US$ Mn), By Sales Channel, 2013-2024
TABLE 4 Global Cancer Supportive Care Market, by Geography, 2013–2024 (US$ Mn)
TABLE 5 North America Cancer Supportive Care Market (US$ Mn), by Country, 2013–2024
TABLE 6 Europe Cancer Supportive Care Market, by Country, 2013–2024 (US$ Mn)
TABLE 7 Europe Cancer Supportive Care Market (US$ Mn), by Country, 2013–2024
TABLE 8 Latin America Cancer Supportive Care Market (US$ Mn), by Type, 2013–2024
TABLE 9 Middle East and Africa Cancer Supportive Care Market (US$ Mn), by Type, 2013–2024
TABLE 10 Amgen Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 11 Novartis AG: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 12 Johnson & Johnson: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 13 Pfizer: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 14 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 15 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 16 Baxter International Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 17 Fagron Group BV: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 18 Helsinn Group: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 19 Acacia Pharma Ltd.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)